Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Wogonoside
2. 51059-44-0
3. Wogonin 7-o-glucuronide
4. Glychionide B
5. Chebi:61282
6. 5,7-dihydroxy-8-methoxyflavone 7-o-beta-d-glucuronide
7. Chembl464732
8. Etx4944z3r
9. (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic Acid
10. Wogonin 7-o-beta-d-glucuronide
11. 5-hydroxy-8-methoxy-4-oxo-2-phenyl-4h-chromen-7-yl Beta-d-glucopyranosiduronic Acid
12. Unii-etx4944z3r
13. Mfcd08704808
14. Wogonin 7-o-beta-glucuronine Methyl Ester
15. Megxp0_000537
16. Acon1_000851
17. Dtxsid80199062
18. Hy-n0399
19. Bdbm50478452
20. S9115
21. Zinc28537647
22. Akos015897144
23. Ccg-269333
24. Wogonoside, >=95% (lc/ms-elsd)
25. Wogonin 7-.beta.-d-glucuronide
26. Ncgc00169296-01
27. Wogonin 7-o-.beta.-d-glucuronide
28. Cs-0008934
29. W0012
30. Wogonin 7-o-.beta.-d-glucuronopyranoside
31. A854472
32. Q3356626
33. W-202920
34. Brd-k72010518-001-01-0
35. (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-((5-hydroxy-8-methoxy-4-oxo-2-phenyl-4h-chromen-7-yl)oxy)tetrahydro-2h-pyran-2-carboxylic Acid
36. .beta.-d-glucopyranosiduronic Acid, 5-hydroxy-8-methoxy-4-oxo-2-phenyl-4h-1-benzopyran-7-yl
37. Ncgc00169296-02!(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic Acid
| Molecular Weight | 460.4 g/mol |
|---|---|
| Molecular Formula | C22H20O11 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 460.10056145 g/mol |
| Monoisotopic Mass | 460.10056145 g/mol |
| Topological Polar Surface Area | 172 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 763 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
59
PharmaCompass offers a list of Wogonoside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Wogonoside manufacturer or Wogonoside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Wogonoside manufacturer or Wogonoside supplier.
PharmaCompass also assists you with knowing the Wogonoside API Price utilized in the formulation of products. Wogonoside API Price is not always fixed or binding as the Wogonoside Price is obtained through a variety of data sources. The Wogonoside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Wogonoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Wogonoside, including repackagers and relabelers. The FDA regulates Wogonoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Wogonoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Wogonoside supplier is an individual or a company that provides Wogonoside active pharmaceutical ingredient (API) or Wogonoside finished formulations upon request. The Wogonoside suppliers may include Wogonoside API manufacturers, exporters, distributors and traders.
Wogonoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Wogonoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Wogonoside GMP manufacturer or Wogonoside GMP API supplier for your needs.
A Wogonoside CoA (Certificate of Analysis) is a formal document that attests to Wogonoside's compliance with Wogonoside specifications and serves as a tool for batch-level quality control.
Wogonoside CoA mostly includes findings from lab analyses of a specific batch. For each Wogonoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Wogonoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Wogonoside EP), Wogonoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Wogonoside USP).
